Myriad Genetics had patented two human genes linked to an increased likelihood of developing breast cancer but it was argued that naturally occurring things can’t be patented. The Supreme Court agreed simply isolating something in nature is not patentable.
|By: Jon Walker Thursday June 13, 2013 10:12 am|
|By: DSWright Tuesday April 16, 2013 2:40 pm|
As the United States Supreme Court decides the limits (or lack thereof) of patenting life, Monsanto is positioning itself to dominate the gene market. After a lengthy legal battle with DuPont and subsequent settlement, Monsanto will likely become the largest Genetically Modified Organism (GMO) company in the world.